GLP-1 Agonists and the Musculoskeletal System

Semaglutide and tirzepatide produce dramatic weight loss — and a clinically significant portion of that loss comes from muscle, not fat. For active patients and those concerned with long-term function, this metabolic trade-off has orthopedic implications that most prescribers are not discussing.